ArticleThe Neurohospitalist2011
Inpatient management of guillain-barré syndrome.
Article in The Neurohospitalist, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021Guideline
- Challenges in managing prolonged intensive care unit stay for Guillain-Barré syndrome-acute motor axonal neuropathy variant.SAGE open medical case reports · 2026Article
- Clinico-epidemiological profile and prediction of outcome in children with Guillain-Barre syndrome.Italian journal of pediatrics · 2025Observational
- Article
- Course and Treatment of a Rare Neurological Sequelae After COVID-19: Miller Fisher Syndrome.Cureus · 2022Article
- Acute motor axonal neuropathy following SARS-CoV-2 infection in the third trimester of pregnancy.Proceedings (Baylor University. Medical Center) · 2022Article
- Guillain-Barré syndrome as the first presentation of human immunodeficiency virus infection.BMC neurology · 2021Article
- Intensive Care and Treatment of Severe Guillain-Barré Syndrome.Frontiers in pharmacology · 2021Review
- Are Repeated Cycles of Intravenous Immunoglobulin Justified in Patients With Poorly Responsive Guillain-Barré Syndrome?The Neurohospitalist · 2020Article
- Newer Immunotherapies for the Treatment of Acute Neuromuscular Disease in the Critical Care Unit.Current treatment options in neurology · 2020Review
- Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear.Journal of translational internal medicine · 2019Review
- Clinical Features Indicating the Need for Mechanical Ventilation in Patients with Guillain Barre Syndrome.Cureus · 2019Article
- Autonomic dysfunction in the neurological intensive care unit.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2019Review
- Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2019Article
- Dysautonomia and hyponatraemia as harbingers of Guillain-Barre syndrome.BMJ case reports · 2019Article
- An Unusual Presentation of Acute Weakness: Acute Inflammatory Demyelinating Polyneuropathy in a Patient with Psychiatric Illness.Case reports in emergency medicine · 2018Article
- New strategies in the management of Guillain-Barré syndrome.Clinical reviews in allergy & immunology · 2014Review
- Use of functional magnetic resonance imaging to assess cognition and consciousness in severe Guillain-Barré syndrome.International journal of clinical and health psychology : IJCHPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis in the developed world. Guillain-Barré syndrome typically presents with ascending paralysis and is usually severe enough to warrant hospital admission for management. In the United States alone, GBS results in more than 6000 hospitalizations each year. Although GBS patients were historically cared for at tertiary referral centers, changing treatment practices have broadened the number of neurologists who care for the disease. This article provides a review of key issues in the inpatient management of GBS. A survey of the evidence base for treatment with plasma exchange or intravenous immunoglobulins is presented. Although either of these treatments can limit the severity of GBS, patients are still at risk for a broad range of complications, including respiratory failure, autonomic dysfunction, thromboembolic disease, pain, and psychiatric disorders. Awareness of these complications, their detection and management, may help limit the morbidity of GBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.